Home › Funds › Ally Bridge Group (NY) LLC › EWTX

Ally Bridge Group (NY) LLC position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Ally Bridge Group (NY) LLC reported holding 185,430 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 10.00% of its reported portfolio and ranking #3 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed EWTX holdings in 7 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)185.43K sh
Reported value held$7.53M
Portfolio Weight10.00%
First reportedQ3 2024
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Ally Bridge Group (NY) LLC's EWTX position evolved

Ally Bridge Group (NY) LLC first disclosed a stake in EWTX in Q3 2024 at 187,695 shares (US$5.0M). The position peaked in Q3 2026 at 185,430 shares, worth US$7.5M. Across 7 filings, Ally Bridge Group (NY) LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 185,430 shares valued at US$7.5M — an increase of 102,130 shares quarter over quarter.. Notable position changes include a 56% trim in Q4 2024 (shares fell 18% over the following quarter), a 48% trim in Q2 2026 (shares were roughly flat over the following quarter), a 123% increase in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 187.69K $5.01M New
Q4 2024 83.18K $2.22M Reduce
Q1 2025 100.00K $2.20M Add
Q4 2025 195.00K $4.84M New
Q1 2026 161.00K $5.07M Reduce
Q2 2026 83.30K $3.38M Reduce
Q3 2026 185.43K $7.53M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.1M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$340.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Ally Bridge Group (NY) LLC held EWTX?

Ally Bridge Group (NY) LLC has disclosed EWTX holdings in 7 of the last 9 reported quarters, going back to Q3 2024.

What is Ally Bridge Group (NY) LLC's current position in EWTX?

As of Q3 2026, Ally Bridge Group (NY) LLC holds 185.43K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $7.53M, representing 10.00% of its reported portfolio and ranking #3.

Has Ally Bridge Group (NY) LLC been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Ally Bridge Group (NY) LLC increased its position in EWTX. The position peaked in Q3 2026 at 185.43K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.